SWITZERLAND DAYBOOK: Novartis’s Menveo Approved by FDA for Kids

Novartis AG won U.S. approval for the Menveo meningococcal vaccine for use in children from two years of age, the company said today in a statement. Novartis received a “refuse to file letter” for use of the vaccine in infants and will resubmit the application, the company said.

EQUITIES: *Kaba Sells Door Automation to Nabtesco for SF220-240 Million

MARKETS: *The SMI lost 0.5 percent to close at 6,528.13 *The SPI fell 0.5 percent to close at 5,854.77 *Euro -- Franc at 1.2808 at 7:38 a.m. Zurich time

To contact the reporter on this story: Paul Verschuur at pverschuur@bloomberg.net

To contact the editor responsible for this story: Angela Cullen at acullen8@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.